| Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer OAW Haabeth, KB Lorvik, C Hammarström, IM Donaldson, G Haraldsen, ... Nature communications 2 (1), 240, 2011 | 337 | 2011 |
| Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens MS Khodadoust, N Olsson, LE Wagar, OAW Haabeth, B Chen, ... Nature 543 (7647), 723-727, 2017 | 261 | 2017 |
| How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules? OAW Haabeth, AA Tveita, M Fauskanger, F Schjesvold, KB Lorvik, ... Frontiers in immunology 5, 174, 2014 | 240 | 2014 |
| Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters CJ McKinlay, NL Benner, OA Haabeth, RM Waymouth, PA Wender Proceedings of the National Academy of Sciences 115 (26), E5859-E5866, 2018 | 189 | 2018 |
| Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an In Situ Inflammatory Immune Response KB Lorvik, C Hammarström, M Fauskanger, OAW Haabeth, M Zangani, ... Cancer research 76 (23), 6864-6876, 2016 | 112 | 2016 |
| mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice OAW Haabeth, TR Blake, CJ McKinlay, RM Waymouth, PA Wender, ... Proceedings of the National Academy of Sciences 115 (39), E9153-E9161, 2018 | 106 | 2018 |
| Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells OAW Haabeth, KB Lorvik, H Yagita, B Bogen, A Corthay Oncoimmunology 5 (1), e1039763, 2016 | 104 | 2016 |
| Local delivery of Ox40l, Cd80, and Cd86 mRNA kindles global anticancer immunity OAW Haabeth, TR Blake, CJ McKinlay, AA Tveita, A Sallets, ... Cancer research 79 (7), 1624-1634, 2019 | 90 | 2019 |
| A model for cancer-suppressive inflammation OAW Haabeth, B Bogen, A Corthay Oncoimmunology 1 (7), 1146-1155, 2012 | 84 | 2012 |
| iNOS-and NOX1-dependent ROS production maintains bacterial homeostasis in the ileum of mice C Matziouridou, SDC Rocha, OA Haabeth, K Rudi, H Carlsen, A Kielland Mucosal immunology 11 (3), 774-784, 2018 | 72 | 2018 |
| CD4+ T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models B Bogen, M Fauskanger, OA Haabeth, A Tveita Cancer Immunology, Immunotherapy 68, 1865-1873, 2019 | 67 | 2019 |
| Tumor killing by CD4+ T cells is mediated via induction of inducible nitric oxide synthase-dependent macrophage cytotoxicity M Fauskanger, OAW Haabeth, FM Skjeldal, B Bogen, AA Tveita Frontiers in immunology 9, 388824, 2018 | 67 | 2018 |
| Oligo(serine ester) Charge-Altering Releasable Transporters: Organocatalytic Ring-Opening Polymerization and their Use for in Vitro and in Vivo mRNA Delivery NL Benner, RL McClellan, CR Turlington, OAW Haabeth, RM Waymouth, ... Journal of the American Chemical Society 141 (21), 8416-8421, 2019 | 65 | 2019 |
| CD4+ T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs OAW Haabeth, M Fauskanger, M Manzke, KU Lundin, A Corthay, ... Cancer research 78 (16), 4573-4585, 2018 | 59 | 2018 |
| An mRNA SARS-CoV-2 vaccine employing charge-altering releasable transporters with a TLR-9 agonist induces neutralizing antibodies and T cell memory OAW Haabeth, JJK Lohmeyer, A Sallets, TR Blake, I Sagiv-Barfi, ... ACS Central Science 7 (7), 1191-1204, 2021 | 38 | 2021 |
| Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy AJ Wilk, NLB Weidenbacher, R Vergara, OAW Haabeth, R Levy, ... Blood Advances 4 (17), 4244-4255, 2020 | 36 | 2020 |
| Tumors Escape CD4+ T-cell–Mediated Immunosurveillance by Impairing the Ability of Infiltrating Macrophages to Indirectly Present Tumor Antigens AA Tveita, F Schjesvold, OA Haabeth, M Fauskanger, B Bogen Cancer research 75 (16), 3268-3278, 2015 | 34 | 2015 |
| Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial MJ Frank, MS Khodadoust, DK Czerwinski, OAW Haabeth, MP Chu, ... Journal of Experimental Medicine 217 (9), e20191712, 2020 | 27 | 2020 |
| Idiotype-specific CD4+ T cells eradicate disseminated myeloma OA Haabeth, A Tveita, M Fauskanger, K Hennig, PO Hofgaard, B Bogen Leukemia 30 (5), 1216-1220, 2016 | 24 | 2016 |
| Indirect CD4+ T‐cell‐mediated elimination of MHC IINEG tumor cells is spatially restricted and fails to prevent escape of antigen‐negative cells AA Tveita, FH Schjesvold, O Sundnes, OAW Haabeth, G Haraldsen, ... European journal of immunology 44 (9), 2625-2637, 2014 | 24 | 2014 |
Robert M. WaymouthProfessor of Chemistry, Stanford UniversityGeverifieerd e-mailadres voor stanford.edu
